RECURRENT LOW GRADE GLIOMA
Clinical trials for RECURRENT LOW GRADE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT LOW GRADE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT LOW GRADE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with brain tumors: drug that crosses the Blood-Brain barrier enters trials
Disease control Recruiting nowThis study tests a drug called mirdametinib in children, adolescents, and young adults with low-grade glioma, a type of brain tumor. The drug is designed to reach the brain and block signals that help tumors grow. The goal is to find the best dose, check safety, and see if it can…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 08:57 UTC
-
Laser zaps brain tumors in kids without open surgery
Disease control Recruiting nowThis study tests a laser treatment called LITT for children, teens, and young adults whose low-grade brain tumors have come back after prior therapy. About 40 participants will receive the laser procedure to heat and destroy tumor cells. The goal is to see if this approach can st…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Can brain tumor patients safely reduce their medication? new study investigates
Disease control Recruiting nowThis study looks at whether people with a slow-growing brain tumor (low-grade glioma) that has a specific gene change (BRAF V600) can safely stop or lower their dose of two targeted drugs (dabrafenib and trametinib) after taking them for 12-24 months. About 96 participants will e…
Matched conditions: RECURRENT LOW GRADE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 13, 2026 16:02 UTC